Literature DB >> 30365438

Pulmonary Arterial Hypertension Emergency Complications and Evaluation: Practical Guide for the Advanced Practice Registered Nurses in the Emergency Department.

Robin Hohsfield1, Christine Archer-Chicko, Traci Housten, Stephanie Harris Nolley.   

Abstract

Pulmonary hypertension (PH) complicates common diseases and can lead to worsening symptoms and increased mortality. A specific group of PH, pulmonary arterial hypertension (PAH), World Health Organization Group 1, may present to the emergency department (ED). We review common ED presentations of patients with PAH such as cardiac arrest/sudden death, right ventricular failure, syncope, hypoxemic respiratory failure, arrhythmias, hemoptysis, pulmonary embolism, chest pain/left main compression syndrome, infection, and considerations for PAH medication administration. We include a case study to illustrate a real example with a positive outcome, and an algorithm for evaluating and triaging patients with PAH in the ED. The ability to recognize, triage, and communicate changes in PAH disease status in a multidisciplinary team approach between the patient, family, specialty pharmacy, and specialized health care providers such as the PH team, is essential for ED providers who are evaluating and treating patients with PAH.

Entities:  

Mesh:

Year:  2018        PMID: 30365438      PMCID: PMC6221388          DOI: 10.1097/TME.0000000000000210

Source DB:  PubMed          Journal:  Adv Emerg Nurs J        ISSN: 1931-4485


  30 in total

Review 1.  [Evidence-based management of right heart failure: a systematic review of an empiric field].

Authors:  Mehdi Skhiri; Sharon A Hunt; André Y Denault; François Haddad
Journal:  Rev Esp Cardiol       Date:  2010-04       Impact factor: 4.753

Review 2.  Clinical policy: Critical issues in the evaluation and management of adult patients presenting to the emergency department with acute heart failure syndromes.

Authors:  Scott M Silvers; John M Howell; Joshua M Kosowsky; Ivan C Rokos; Andy S Jagoda
Journal:  Ann Emerg Med       Date:  2007-04-03       Impact factor: 5.721

3.  Hemodynamic importance of systolic ventricular interaction, augmented right atrial contractility and atrioventricular synchrony in acute right ventricular dysfunction.

Authors:  J A Goldstein; A Harada; Y Yagi; B Barzilai; J L Cox
Journal:  J Am Coll Cardiol       Date:  1990-07       Impact factor: 24.094

Review 4.  Definitions and diagnosis of pulmonary hypertension.

Authors:  Marius M Hoeper; Harm Jan Bogaard; Robin Condliffe; Robert Frantz; Dinesh Khanna; Marcin Kurzyna; David Langleben; Alessandra Manes; Toru Satoh; Fernando Torres; Martin R Wilkins; David B Badesch
Journal:  J Am Coll Cardiol       Date:  2013-12-24       Impact factor: 24.094

Review 5.  The CRASH report: emergency management dilemmas facing acute physicians in patients with pulmonary arterial hypertension.

Authors:  Laura C Price; Konstantinos Dimopoulos; Philip Marino; Rafael Alonso-Gonzalez; Colm McCabe; Aleksander Kemnpy; Lorna Swan; Maria Boutsikou; Ahmed Al Zahrani; Gerry J Coghlan; Benjamin E Schreiber; Luke S Howard; Rachel Davies; Mark Toshner; Joanna Pepke-Zaba; Alistair C Church; Andrew Peacock; Paul A Corris; James L Lordan; Sean Gaine; Robin Condliffe; David G Kiely; Stephen John Wort
Journal:  Thorax       Date:  2017-09-12       Impact factor: 9.139

Review 6.  Optimising the management of pulmonary arterial hypertension patients: emergency treatments.

Authors:  M Delcroix; R Naeije
Journal:  Eur Respir Rev       Date:  2010-09

Review 7.  Pathophysiology and treatment of haemodynamic instability in acute pulmonary embolism: the pivotal role of pulmonary vasoconstriction.

Authors:  Y M Smulders
Journal:  Cardiovasc Res       Date:  2000-10       Impact factor: 10.787

8.  Micrococcus-associated central venous catheter infection in patients with pulmonary arterial hypertension.

Authors:  Ronald J Oudiz; Allison Widlitz; X Joy Beckmann; Daisy Camanga; Jose Alfie; Bruce H Brundage; Robyn J Barst
Journal:  Chest       Date:  2004-07       Impact factor: 9.410

Review 9.  A global view of pulmonary hypertension.

Authors:  Marius M Hoeper; Marc Humbert; Rogerio Souza; Majdy Idrees; Steven M Kawut; Karen Sliwa-Hahnle; Zhi-Cheng Jing; J Simon R Gibbs
Journal:  Lancet Respir Med       Date:  2016-03-12       Impact factor: 30.700

10.  Systemic and pulmonary hypertension after abrupt cessation of prostacyclin: role of thromboxane A2.

Authors:  L L Cuiper; P V Price; B W Christman
Journal:  J Appl Physiol (1985)       Date:  1996-01
View more
  1 in total

1.  Pharmacokinetics and tolerability of LIQ861, a novel dry-powder formulation of treprostinil.

Authors:  Robert Roscigno; Toby Vaughn; Stephanie Anderson; William Wargin; Thomas Hunt; Nicholas S Hill
Journal:  Pulm Circ       Date:  2020-11-19       Impact factor: 3.017

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.